TE
Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
$1.24 +0.81% (+$0.01)
1M +5.98%
Market Cap $85.3M
P/E Ratio -
Div. Yield -
ROE 102.69%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 16.94x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 109.51%
ROIC 120.93%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -837.07x
Debt/Equity 0.00x
Current ratio 16.14x
Stability
19 /100
Unstable Profitable years 0
Beta -0.25x
EPS volatility 829.02%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TELO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Erez Aminov
Employees
2
Headquarters
Miami
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report